Interestingly, we find reduced HDAC activity in the nucleus of IPF fibroblasts, which apparently is in contrast to previous reports28–30 that propose the use of HDAC inhibitors as potential treatment against pulmonary fibrosis. Here, HDAC9 is linked to pulmonary fibrosis.